camidanlumab tesirine (ADCT-301)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

ADC Therapeutics, Genmab

Drug class:

DNA replication inhibitor, CD25-targeted antibody-drug conjugate

Related drugs:

‹

›

IL2RA expression	Non-Hodgkin’s Lymphoma	IL2RA expression	Non-Hodgkin’s Lymphoma	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D
IL2RA expression	Colorectal Cancer	IL2RA expression	Colorectal Cancer	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D
ALK positive	Non-Hodgkin’s Lymphoma	ALK positive	Non-Hodgkin’s Lymphoma	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D

Associations
(3)